See exactly which plans in your area include Tresiba®. Formulary status is believed to be accurate at the time of update but cannot be guaranteed.
Find out more information on financial assistance and patient access support ▾
See exactly which plans in your area include Tresiba®. Formulary status is believed to be accurate at the time of update but cannot be guaranteed.
Find out more information on financial assistance and patient access support ▾
NovoCare® is a go-to resource to help patients on their treatment journey.
Find out if your patient’s insurance plan covers Tresiba®, and then quickly calculate their co-pay.
Once coverage is confirmed, prior authorizations (PAs) may be necessary for some patients.
NovoCare® is a go-to resource to help patients on their treatment journey.
Find out if your patient’s insurance plan covers Tresiba®, and then quickly calculate their co-pay.
Once coverage is confirmed, prior authorizations (PAs) may be necessary for some patients.
The Novo Nordisk Patient Assistance Program is based on our commitment to people living with diabetes. The PAP provides medication at no cost to those who qualify, and patients who are approved may receive free diabetes medicine from Novo Nordisk for up to a year. There is no registration charge or monthly fee for participating.
aFull patient eligibility requirements can be found at NovoCare.com.
Tresiba® (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Tresiba® is not recommended for treating diabetic ketoacidosis.